Contribute
España
Italia
대한민국
日本
Français
Benzinga
Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
769.450.1%
QQQ
717.500.2%
BTC/USD
79950.130.1372%
DIA
532.880.22%
GLD
406.530.06%
TLT
82.240.04%

Iovance Biotherapeutics Inc (IOVA) Stock Price, Quote, News & History

IOVANASDAQ
Trade with Public
Trade with Public
$8.79
0.091.03%
At close: Sep 4, 5:00 PM EST
$8.78
-0.0114-0.13%
After Hours: Sep 4, 7:59 PM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareOptionsStock Report

Iovance Biotherapeutics (IOVA) Stock Price, Quote, News & History | Benzinga

Key Statistics

Open
$8.74
Close
$8.79
Volume / Avg.
8.08M / 16.36M
Day Range
$8.64 - $8.90
52 Wk Range
1.76 - 9.36
Market Cap
$3.92B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
70
Short Interest
24.68%
Days to Cover
4.79

Recent Iovance Biotherapeutics Inc News

Iovance Biotherapeutics Stock Is Trending Friday: What's Going On?

Shares of Iovance Biotherapeutics are trending Friday morning after a momentum surge pushed the biotech stock to a new 52-week high.
Henry Khederian

Why Iovance Biotherapeutics Stock Hit 52-Week High

Iovance Biotherapeutics stock hits a 52-week high as investors weigh Moderna-Merck cancer data, Amtagvi sales and analyst price target hikes.
Vandana Singh

Deere, Coinbase Global, Nordson And Other Big Stocks Moving Higher On Wednesday

Dow Jones down 300 points, Deere & Co shares up 7.9% after beating earnings expectations. SCTX, SCSC, BTBT, MRVI, HIVE, AHG, TEM, MARA, LB also gain.
Avi Kapoor

Estee Lauder, Moderna, Merck And Other Big Stocks Moving Higher On Wednesday

Dow Jones up 200 points on Wed. Estee Lauder & other top stocks record gains after reporting strong Q4 results and positive sales guidance.
Avi Kapoor

Iovance (IOVA) Stock Soars After Better-Than-Expected Q2 Results

Iovance Biotherapeutics Inc (NASDAQ:IOVA) shares are surging Thursday after the cancer therapy company shattered second-quarter expectations on both the top and bottom lines. Here's what you should know.
Evette Mitkov

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-264.18M
Investing Cash Flow (TTM)
-44.87M
Financing Cash Flow (TTM)
287.85M
Free Cash Flow (TTM)
-296.40M
Capital Expenditure (TTM)
-32.21M
Net Change in Cash (TTM)
-21.20M

Analyst Trends and Forecast

1
Apr
1
May
3
1
Aug
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$3.91B
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
11.00
PB Ratio (TTM)
5.46
Earnings Yield % (TTM)
-7.92%
Earnings Yield % (FWD)
-4.02%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$1.60

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$110.77M
Debt to Equity
0.06
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$8.74
Close
$8.79
Volume / Avg.
8.08M / 16.36M
Day Range
$8.64 - $8.90
52 Wk Range
1.76 - 9.36
Market Cap
$3.92B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
70
Short Interest
24.68%
Days to Cover
4.79

About

Sector
Health Care
Industry
Biotechnology
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies persona...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Iovance Biotherapeutics (IOVA) stock?

A

You can purchase shares of Iovance Biotherapeutics (NASDAQ:IOVA) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Iovance Biotherapeutics (IOVA) competitors?

Q

What is the forecast, or price target, for Iovance Biotherapeutics (IOVA) stock?

A

Iovance Biotherapeutics has a consensus price target of $11.71.

Q

What is the current price for Iovance Biotherapeutics (IOVA)?

A

The stock price for Iovance Biotherapeutics (NASDAQ: IOVA) is $8.7786 last updated September 4, 2026 at 7:59 PM EDT.

Q

Does Iovance Biotherapeutics (IOVA) pay a dividend?

A

There are no upcoming dividends for Iovance Biotherapeutics.

Q

When is Iovance Biotherapeutics (NASDAQ:IOVA) reporting earnings?

A

Iovance Biotherapeutics does not have any upcoming earnings scheduled.

Q

Is Iovance Biotherapeutics (IOVA) going to split?

A

There is no upcoming split for Iovance Biotherapeutics.

Q

What sector and industry does Iovance Biotherapeutics (IOVA) operate in?

A

Iovance Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved